Abstract: A predictive method of cellular, tissue and clinical radiosensitivity, which is based on the determination and cross-checking of a plurality of cellular and enzymatic parameters and criteria applied to a tumor response. The predictive method characterizes the sensitivity of a tumor in response to a DNA-breaking radiotherapy treatment.
Type:
Application
Filed:
August 16, 2016
Publication date:
August 23, 2018
Applicants:
NEOLYS DIAGNOSTICS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, CENTRE LEON BERARD, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CLAUDE BERNARD LYON 1
Inventors:
Nicolas FORAY, Larry BODGI, Sandrine PEREIRA